Comments
Search
Ticker Summary (GSK)
| 35.17+0.01 (+0.03%) | |
|---|---|
| Open | 34.86 |
| High | 35.40 |
| Low | 34.85 |
| Volume | 2,496,475 |
| Market Cap | 91.3B |
| 52 Week High | 43.47 |
| 52 Week Low | 32.15 |
| P/E | 14.41 |
| F P/E | 9.16 |
| EPS | 2.44 |
| Dividend | 1.98 |
| Yield | 5.63% |
| 1 Year Target | 41.56 |
GSK 35.17 +0.03%
GlaxoSmithKline has agreed to acquire Reliant Pharmaceuticals for $1.65 billion in cash. The move is expected to increase its drug sales in the U.S. Glaxo has had a rough couple of months after slowing sales of its core diabetes drug Avandia, following a report linking the drug to increased heart-attack risks.
+0
| Circulate
Submit comment
Please sign in or register to leave a comment.
Top 10 in GSK
1.
